Michele Cavo
Michele Cavo
Professor of Hematology
Verified email at
Cited by
Cited by
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ...
The lancet oncology 15 (12), e538-e548, 2014
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ...
The lancet oncology 17 (8), e328-e346, 2016
Revised international staging system for multiple myeloma: a report from International Myeloma Working Group
A Palumbo, H Avet-Loiseau, S Oliva, HM Lokhorst, H Goldschmidt, ...
Journal of clinical oncology 33 (26), 2863, 2015
Idecabtagene vicleucel in relapsed and refractory multiple myeloma
NC Munshi, LD Anderson Jr, N Shah, D Madduri, J Berdeja, S Lonial, ...
New England Journal of Medicine 384 (8), 705-716, 2021
Oral ixazomib, lenalidomide, and dexamethasone for multiple myeloma
P Moreau, T Masszi, N Grzasko, NJ Bahlis, M Hansson, L Pour, I Sandhu, ...
New England Journal of Medicine 374 (17), 1621-1634, 2016
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A Dispenzieri, R Kyle, G Merlini, JS Miguel, H Ludwig, R Hájek, ...
Leukemia 23 (2), 215-224, 2009
Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma
A Palumbo, SV Rajkumar, MA Dimopoulos, PG Richardson, J San Miguel, ...
Leukemia 22 (2), 414-423, 2008
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label …
J San Miguel, K Weisel, P Moreau, M Lacy, K Song, M Delforge, L Karlin, ...
The lancet oncology 14 (11), 1055-1066, 2013
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149-157, 2012
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem …
M Cavo, P Tacchetti, F Patriarca, MT Petrucci, L Pantani, M Galli, ...
The Lancet 376 (9758), 2075-2085, 2010
Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma
MV Mateos, MA Dimopoulos, M Cavo, K Suzuki, A Jakubowiak, S Knop, ...
New England Journal of Medicine 378 (6), 518-528, 2018
Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma
L Benboubker, MA Dimopoulos, A Dispenzieri, J Catalano, AR Belch, ...
New England Journal of Medicine 371 (10), 906-917, 2014
Continuous lenalidomide treatment for newly diagnosed multiple myeloma
A Palumbo, R Hajek, M Delforge, M Kropff, MT Petrucci, J Catalano, ...
New England Journal of Medicine 366 (19), 1759-1769, 2012
Autologous transplantation and maintenance therapy in multiple myeloma
A Palumbo, F Cavallo, F Gay, F Di Raimondo, D Ben Yehuda, MT Petrucci, ...
New England Journal of Medicine 371 (10), 895-905, 2014
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types
C Rapezzi, G Merlini, CC Quarta, L Riva, S Longhi, O Leone, F Salvi, ...
Circulation 120 (13), 1203-1212, 2009
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Moreau, J San Miguel, P Sonneveld, MV Mateos, E Zamagni, ...
Annals of oncology 28, iv52-iv61, 2017
IMWG consensus on risk stratification in multiple myeloma
WJ Chng, A Dispenzieri, CS Chim, R Fonseca, H Goldschmidt, ...
Leukemia 28 (2), 269-277, 2014
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a …
M Attal, PG Richardson, SV Rajkumar, J San-Miguel, M Beksac, I Spicka, ...
The Lancet 394 (10214), 2096-2107, 2019
Proteasome inhibitors in multiple myeloma: 10 years later
P Moreau, PG Richardson, M Cavo, RZ Orlowski, JF San Miguel, ...
Blood, The Journal of the American Society of Hematology 120 (5), 947-959, 2012
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
MA Dimopoulos, P Moreau, E Terpos, MV Mateos, S Zweegman, G Cook, ...
Hemasphere 5 (2), e528, 2021
The system can't perform the operation now. Try again later.
Articles 1–20